Nutex Health Inc. (NASDAQ:NUTX) Given Consensus Rating of “Moderate Buy” by Brokerages

Nutex Health Inc. (NASDAQ:NUTX) has been assigned an average rating of “Moderate Buy” from the five brokerages that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $243.3333.

Several equities analysts have commented on NUTX shares. Lake Street Capital began coverage on shares of Nutex Health in a report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 target price on the stock. Zacks Research raised shares of Nutex Health to a “hold” rating in a research note on Monday, June 29th. B. Riley Financial assumed coverage on shares of Nutex Health in a research report on Friday, June 26th. They set a “buy” rating and a $290.00 price objective for the company. Weiss Ratings cut Nutex Health from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, July 10th. Finally, Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th.

Nutex Health Stock Performance

NUTX opened at $145.87 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.12 and a current ratio of 3.14. Nutex Health has a 52-week low of $77.21 and a 52-week high of $204.00. The firm has a market cap of $1.00 billion, a P/E ratio of 11.27 and a beta of 0.21. The business’s fifty day moving average is $151.54 and its 200-day moving average is $130.66.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.The business had revenue of $216.49 million during the quarter, compared to the consensus estimate of $227.80 million. Sell-side analysts expect that Nutex Health will post 22.72 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Topline Capital Management LLC grew its holdings in Nutex Health by 72.0% during the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock worth $38,484,000 after acquiring an additional 129,418 shares during the last quarter. Millennium Management LLC raised its stake in shares of Nutex Health by 191.1% during the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after acquiring an additional 61,308 shares during the last quarter. Pertento Partners LLP raised its stake in shares of Nutex Health by 20.0% during the fourth quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock valued at $53,406,000 after acquiring an additional 54,001 shares during the last quarter. Empowered Funds LLC acquired a new position in shares of Nutex Health during the first quarter worth $3,084,000. Finally, SG Americas Securities LLC lifted its holdings in shares of Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after purchasing an additional 29,449 shares during the period. Institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.